Rare Bird Foundation is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G01). Contributions are tax-deductible.
443 Bel Air Dr, Glenview, IL 60025-4808
Among the 4 scored disease & disorders organizations in Glenview, Rare Bird Foundation holds 4.7 months of operating reserves (peer median 4.1 months), runs a typical yearly surplus of 3463.4% (peers: deficit of 3.8%), and has grown spending 8129.9% a year (peers: grown spending 38.0% a year).
In fiscal year 2025 it reported $126,861 in revenue and $234,471 in expenses, with contributions making up 100.0% of revenue.
Working with our partners worldwide , Rare Bird aims to create the first-ever globally approved drug to tackle the transcription factor Myocyte Enhancer Factor 2C MEF2C deficiency within five years.
Main program · fiscal year 2025
Our flagship program is the MEF2C Haploinsufficiency Syndrome communitys first ever natural history study and clinical readiness study out of Weill Cornell Medical Center. We paid 231141 to Cornell to pay for one of five milestone payments.The expenses were used by Cornell to pay for clinical staff, research fees, and travel expenses for patients in accordance with the Studys contractual terms.$234,141 spent
Where each dollar went · fiscal year 2025
Of every dollar it spent, 100¢ went to programs, 0¢ to management and 0¢ to fundraising.
Programs $234,141
Management $330
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
100%
Meets
Compared with Glenview peers
Measure
This organization
Peer median
Operating reserves
4.7 mo
4.1 mo
Typical margin
+3463.4%
−3.8%
Spending growth
+8129.9% / yr
+38.0% / yr
Debt load
0.0%
1.6%
Peers: the 4 Glenview disease & disorders organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$126,861Fiscal year 2025
Expenses$234,471Fiscal year 2025
Total assets$91,041Fiscal year 2025
Total liabilities$0Fiscal year 2025
Fiscal year ending December2025
Revenue$126,861
Expenses$234,471
Net income−$107,610
Net assets$91,041
Notable sources of revenue
Percent of total revenue
Contributions
$126,861
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$91,041
Total liabilities
$0
Net assets
$91,041
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$201,500
Expenses$2,849
Net income$198,651
Net assets$198,651
Notable sources of revenue
Percent of total revenue
Contributions
$201,500
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$198,651
Total liabilities
$0
Net assets
$198,651
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?